NBIX
Neurocrine Biosciences·NASDAQ
--
--(--)
--
--(--)
6.04 / 10
Outperform
Analyst sentiment is neutral with a 4.29 weighted rating; 50% Strong Buy, 25% Buy, 25% Neutral from four reports. Capital flow is robust (7.78/10) with positive Small and Medium trends, though overall block trends are negative. This combination suggests institutional caution but retail-level accumulation, supporting a balanced, not overly aggressive, investment stance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
25%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-12
InstitutionJP Morgan
Times predicted4
Historical Win Rate50.0%
Is money flowing into or out of NBIX?
- NBIX holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.04/10 (Outperform).
